OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production within Chinese hamster ovary (CHO) cells is a paramount challenge with Antibody Expression the biopharmaceutical industry. A variety of strategies can be employed enhance antibody titer, including process parameter optimization, cell line development, and the use of perfusion technologies. Fine-